CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Medicare claims data can aid development decisions: NIC MAP Vision
By
Kathleen Steele Gaivin
Oct 05, 2021
Operators trying to determine which markets are under- or over-served can use Medicare data to make better development decisions, according to Arick Morton, CEO of NIC MAP Vision.
Fund Alzheimer’s research, Senate committee told
By
Lois A. Bowers
Apr 06, 2016
Witnesses testifying before the Senate Special Committee on Aging, and committee members themselves, called for more funding for Alzheimer’s research at an April 6 hearing.